TABLE 2 Summary of genes in D3-1 cells whose expression is decreased by 24-h treatment with EGCG

TABLE 3 Summary of genes in D3-1 cells whose expression is increased by 24-hour treatment with EGCG

Table S1: The 259 Genes Predicting Survival Identified Using SPC

Tableÿ1. Human imprinted genes identified by GeneChip

Table 1. Differentially expressed genes found in both BT549ga1 25 A and BT549SE51

Supplementary Table 2 Complete list of differentially expressed genes in wild-type but not in phospho-mutant galectin-3 transfectants

Table 2. Partial list of differentially expressed genes in BT549gal 25A but not BT549SE51

Table 1. Functional categorization of differentially expressed genes in PARP-1+/+ and PARP-1?/? MEFs after arsenite treatment

Table 2 Genes differentially expressed between the tamoxifen and control groups and assigned to the generated networks All other genes can be found on our website www2.eur.nl/fgg//rede/gielen.

Supplementary Table S7: Candidate genes associated with t-ML development after ALL treatment. Using a cumulative incidence regression model among the 267 B- or T-lineage patients  we found 238 probes significantly associated with time to t-ML development (? = 0.01).

Supplementary Table S1: Candidate genes associated with t-ML development after ALL treatment. Using a cumulative incidence regression model among the 228 B-lineage patients  we found 256 probes significantly associated with time to t-ML development (? = 0.01).

Supplementary Table S11: Candidate genes associated with t-ML development among the 267 B- or T-lineage patients. We found 68 probes in common using a cumulative incidence regression model and a Cox regression model (??= 0.01).

Table 1. Candidate genes associated with t-ML development after ALL treatment among 228 B-lineage patients

Supplementary Table S2: Candidate genes associated with t-ML development after ALL treatment. Using a Cox regression model among the 228 B-lineage patients  we found 83 probes significantly associated with t-ML development (? = 0.01).